Perceived Stress and Black Rice (Oryza Sativa L.) Extract Fermented With Lactobacillus
1 other identifier
interventional
80
1 country
1
Brief Summary
The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects and tolerability of black rice (Oryza Sativa L.) extract fermented with Lactobacillus on patients with perceived stress for 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2022
CompletedFirst Submitted
Initial submission to the registry
October 13, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedApril 9, 2024
April 1, 2024
2 years
October 13, 2023
April 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
stress response inventory (SRI)
using SRI score. The minimum score was 0, and the maximum score was 195; higher scores mean a worse outcome.
8 weeks
Secondary Outcomes (15)
perceived stress scale (PSS)
8 weeks
stress-Visual Analog Scale (VAS)
8 weeks
EuroQol (EQ)-5D-5L
8 weeks
Salivary cortisol (ng/dl)
8 weeks
Plasma cortisol (ng/dl)
8 weeks
- +10 more secondary outcomes
Study Arms (2)
Fermented rice group
EXPERIMENTALThis group takes black rice (Oryza Sativa L.) extract fermented with Lactobacillus for 8 weeks.
Control group
PLACEBO COMPARATORThis group takes a placebo for 8 weeks.
Interventions
1,000 mg of black rice (Oryza Sativa L.) extract fermented with Lactobacillus for 8 weeks
Eligibility Criteria
You may qualify if:
- \- the Perceived Stress Scale between 13-18
You may not qualify if:
- People with alcohol use/induced disorders
- Persons with brain disease or undergoing rehabilitation treatment for brain disease
- Patients with mental illnesses such as major affective disorder, post-traumatic stress disorder, uncontrolled obsessive-compulsive disorder, schizophrenia, dementia, drug addiction, etc.
- Those who have taken psychotropic drugs, sleeping pills, appetite suppressants, oral steroids, and corticosteroids within 1 month before starting the trial
- Those who have taken functional health foods recognized by the Ministry of Food and Drug Safety related to relieving tension caused by stress and improving sleep within 1 month before the start of the test
- Those who show withdrawal symptoms due to abstinence from drinking or smoking within 1 month before starting the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pusan National University Yangsan Hospital
Yangsan, Gyeungsangnam-do, 50612, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Sang Yeoup Lee, MD, PhD
Pusan National University Yangsan Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 13, 2023
First Posted
October 19, 2023
Study Start
January 3, 2022
Primary Completion
December 30, 2023
Study Completion
December 31, 2023
Last Updated
April 9, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share